Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 139 Pages
Report ld: 6924702
Request Sample
Customized Report
Polycaprolactam Market Size(US$)

CAGR 2026-2032
6.3%
Market Size,2032
USD 12,930
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
The North American market for Polycaprolactam was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Polycaprolactam was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Polycaprolactam was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Polycaprolactam market include BASF SE, Honeywell, Royal DSM N.V, Lanxess, Clariant Corporation, Unitika, DOMO Chemicals, Firestone Textiles Company, Grupa Azoty, LIBOLON, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Polycaprolactam, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Polycaprolactam market size, estimations, and forecasts are presented in terms of sales volume (K MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Polycaprolactam.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Polycaprolactam manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Polycaprolactam sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Polycaprolactam sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Polycaprolactam Product Introduction
1.2 Global Polycaprolactam Market Size Forecast
1.2.1 Global Polycaprolactam Sales Value (2021–2032)
1.2.2 Global Polycaprolactam Sales Volume (2021–2032)
1.2.3 Global Polycaprolactam Sales Price (2021–2032)
1.3 Polycaprolactam Market Trends & Drivers
1.3.1 Polycaprolactam Industry Trends
1.3.2 Polycaprolactam Market Drivers & Opportunities
1.3.3 Polycaprolactam Market Challenges
1.3.4 Polycaprolactam Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polycaprolactam Players Revenue Ranking (2025)
2.2 Global Polycaprolactam Revenue by Company (2021–2026)
2.3 Global Polycaprolactam Sales Volume Ranking of Players (2025)
2.4 Global Polycaprolactam Sales Volume by Company (2021–2026)
2.5 Global Polycaprolactam Average Price by Company (2021–2026)
2.6 Key Manufacturers Polycaprolactam Manufacturing Base and Headquarters
2.7 Key Manufacturers Polycaprolactam Product Offerings
2.8 Key Manufacturers Start of Mass Production of Polycaprolactam
2.9 Polycaprolactam Market Competitive Analysis
2.9.1 Polycaprolactam Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Polycaprolactam Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Polycaprolactam revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Polycaprolactam Market Classification
3.1 Introduction by Type
3.1.1 Standard Type
3.1.2 Reinforced Type
3.1.3 Global Polycaprolactam Sales Value by Type
3.1.3.1 Global Polycaprolactam Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Polycaprolactam Sales Value, by Type (2021–2032)
3.1.3.3 Global Polycaprolactam Sales Value, by Type (%), 2021–2032
3.1.4 Global Polycaprolactam Sales Volume by Type
3.1.4.1 Global Polycaprolactam Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Polycaprolactam Sales Volume, by Type (2021–2032)
3.1.4.3 Global Polycaprolactam Sales Volume, by Type (%), 2021–2032
3.1.5 Global Polycaprolactam Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Automotive
4.1.2 Machinery
4.1.3 Electronic Appliances
4.1.4 Chemical Building Materials
4.2 Global Polycaprolactam Sales Value by Application
4.2.1 Global Polycaprolactam Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Polycaprolactam Sales Value, by Application (2021–2032)
4.2.3 Global Polycaprolactam Sales Value, by Application (%), 2021–2032
4.3 Global Polycaprolactam Sales Volume by Application
4.3.1 Global Polycaprolactam Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Polycaprolactam Sales Volume, by Application (2021–2032)
4.3.3 Global Polycaprolactam Sales Volume, by Application (%), 2021–2032
4.4 Global Polycaprolactam Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Polycaprolactam Sales Value by Region
5.1.1 Global Polycaprolactam Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Polycaprolactam Sales Value by Region (2021–2026)
5.1.3 Global Polycaprolactam Sales Value by Region (2027–2032)
5.1.4 Global Polycaprolactam Sales Value by Region (%), 2021–2032
5.2 Global Polycaprolactam Sales Volume by Region
5.2.1 Global Polycaprolactam Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Polycaprolactam Sales Volume by Region (2021–2026)
5.2.3 Global Polycaprolactam Sales Volume by Region (2027–2032)
5.2.4 Global Polycaprolactam Sales Volume by Region (%), 2021–2032
5.3 Global Polycaprolactam Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Polycaprolactam Sales Value, 2021–2032
5.4.2 North America Polycaprolactam Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Polycaprolactam Sales Value, 2021–2032
5.5.2 Europe Polycaprolactam Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Polycaprolactam Sales Value, 2021–2032
5.6.2 Asia Pacific Polycaprolactam Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Polycaprolactam Sales Value, 2021–2032
5.7.2 South America Polycaprolactam Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polycaprolactam Sales Value, 2021–2032
5.8.2 Middle East & Africa Polycaprolactam Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polycaprolactam Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Polycaprolactam Sales Value and Sales Volume
6.2.1 Key Countries/Regions Polycaprolactam Sales Value, 2021–2032
6.2.2 Key Countries/Regions Polycaprolactam Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Polycaprolactam Sales Value, 2021–2032
6.3.2 United States Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Polycaprolactam Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Polycaprolactam Sales Value, 2021–2032
6.4.2 Europe Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Polycaprolactam Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Polycaprolactam Sales Value, 2021–2032
6.5.2 China Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.5.3 China Polycaprolactam Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Polycaprolactam Sales Value, 2021–2032
6.6.2 Japan Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Polycaprolactam Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Polycaprolactam Sales Value, 2021–2032
6.7.2 South Korea Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Polycaprolactam Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Polycaprolactam Sales Value, 2021–2032
6.8.2 Southeast Asia Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Polycaprolactam Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Polycaprolactam Sales Value, 2021–2032
6.9.2 India Polycaprolactam Sales Value by Type (%), 2025 vs 2032
6.9.3 India Polycaprolactam Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BASF SE
7.1.1 BASF SE Company Information
7.1.2 BASF SE Introduction and Business Overview
7.1.3 BASF SE Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BASF SE Polycaprolactam Product Offerings
7.1.5 BASF SE Recent Developments
7.2 Honeywell
7.2.1 Honeywell Company Information
7.2.2 Honeywell Introduction and Business Overview
7.2.3 Honeywell Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Honeywell Polycaprolactam Product Offerings
7.2.5 Honeywell Recent Developments
7.3 Royal DSM N.V
7.3.1 Royal DSM N.V Company Information
7.3.2 Royal DSM N.V Introduction and Business Overview
7.3.3 Royal DSM N.V Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Royal DSM N.V Polycaprolactam Product Offerings
7.3.5 Royal DSM N.V Recent Developments
7.4 Lanxess
7.4.1 Lanxess Company Information
7.4.2 Lanxess Introduction and Business Overview
7.4.3 Lanxess Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Lanxess Polycaprolactam Product Offerings
7.4.5 Lanxess Recent Developments
7.5 Clariant Corporation
7.5.1 Clariant Corporation Company Information
7.5.2 Clariant Corporation Introduction and Business Overview
7.5.3 Clariant Corporation Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Clariant Corporation Polycaprolactam Product Offerings
7.5.5 Clariant Corporation Recent Developments
7.6 Unitika
7.6.1 Unitika Company Information
7.6.2 Unitika Introduction and Business Overview
7.6.3 Unitika Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Unitika Polycaprolactam Product Offerings
7.6.5 Unitika Recent Developments
7.7 DOMO Chemicals
7.7.1 DOMO Chemicals Company Information
7.7.2 DOMO Chemicals Introduction and Business Overview
7.7.3 DOMO Chemicals Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 DOMO Chemicals Polycaprolactam Product Offerings
7.7.5 DOMO Chemicals Recent Developments
7.8 Firestone Textiles Company
7.8.1 Firestone Textiles Company Company Information
7.8.2 Firestone Textiles Company Introduction and Business Overview
7.8.3 Firestone Textiles Company Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Firestone Textiles Company Polycaprolactam Product Offerings
7.8.5 Firestone Textiles Company Recent Developments
7.9 Grupa Azoty
7.9.1 Grupa Azoty Company Information
7.9.2 Grupa Azoty Introduction and Business Overview
7.9.3 Grupa Azoty Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Grupa Azoty Polycaprolactam Product Offerings
7.9.5 Grupa Azoty Recent Developments
7.10 LIBOLON
7.10.1 LIBOLON Company Information
7.10.2 LIBOLON Introduction and Business Overview
7.10.3 LIBOLON Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 LIBOLON Polycaprolactam Product Offerings
7.10.5 LIBOLON Recent Developments
7.11 Polymeric Resources Corporation
7.11.1 Polymeric Resources Corporation Company Information
7.11.2 Polymeric Resources Corporation Introduction and Business Overview
7.11.3 Polymeric Resources Corporation Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Polymeric Resources Corporation Polycaprolactam Product Offerings
7.11.5 Polymeric Resources Corporation Recent Developments
7.12 UBE
7.12.1 UBE Company Information
7.12.2 UBE Introduction and Business Overview
7.12.3 UBE Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 UBE Polycaprolactam Product Offerings
7.12.5 UBE Recent Developments
7.13 EMS-Grivory
7.13.1 EMS-Grivory Company Information
7.13.2 EMS-Grivory Introduction and Business Overview
7.13.3 EMS-Grivory Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 EMS-Grivory Polycaprolactam Product Offerings
7.13.5 EMS-Grivory Recent Developments
7.14 Shakespeare
7.14.1 Shakespeare Company Information
7.14.2 Shakespeare Introduction and Business Overview
7.14.3 Shakespeare Polycaprolactam Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Shakespeare Polycaprolactam Product Offerings
7.14.5 Shakespeare Recent Developments
8 Industry Chain Analysis
8.1 Polycaprolactam Industrial Chain
8.2 Polycaprolactam Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Polycaprolactam Sales Model
8.5.2 Sales Channels
8.5.3 Polycaprolactam Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 142
USD 2900.00
(Single User License)
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 166
USD 4900.00
(Single User License)
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 4250.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-02-24
Pages: 105
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-31
Pages: 103
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-16
Pages: 121
USD 3950.00
(Single User License)
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-04-27
Pages: 142
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 166
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 121
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-02-24
Pages: 105
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-31
Pages: 103
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-16
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now